Johnson & Johnson has told Indian authorities it will shortly begin clinical trials of its single-shot Covid-19 vaccine from the nation.
The report comes as numerous vaccination centers in India grapple with a lack of vaccine supplies as the nation of 1.3 billion is currently combating another tide of Covid-19 infections that’s eclipsed the earliest. India’s government, however, has said there isn’t any lack of shots.
India now has two accepted vaccines in use, one Developed by Oxford University and AstraZeneca and another, a shooter from neighborhood participant Bharat Biotech.
You will find additional vaccine candidates in trials in India such as Russia’s Sputnik-V, for which neighborhood drugmaker Dr. Reddy is Currently conducting trials. Another shot manufactured by Cadila Healthcare Ltd can be in trials.